Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells

Cancer Letters

Volumn 362, Issue 2, 2015, Pages 167-173

  Vares, Guillaume ^a   Sai, Sei ^b   Wang, Bing ^a   Fujimori, Akira ^a   Nenoi, Mitsuru ^a   Nakajima, Tetsuo ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Basal breast cancer; Cancer stem cells; Membrane progesterone receptor; MiRNA; Progesterone; Radiation

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD24 ANTIGEN; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR 4; MICRORNA 29; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN KINASE B; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; KRUPPEL LIKE FACTOR; MICRORNA; MIRN29 MICRORNA, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; BREAST CELL; CANCER RISK; CANCER STEM CELL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; X RAY; CELL LINE; DRUG EFFECTS; FEMALE; GENETIC TRANSFECTION; MAMMARY GLAND; METABOLISM; PATHOLOGY; RADIATION RESPONSE;

GASTROPODA;

CELL LINE; DOWN-REGULATION; FEMALE; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MAMMARY GLANDS, HUMAN; MICRORNAS; NEOPLASTIC STEM CELLS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROGESTERONE; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION; UP-REGULATION;

EID: 84928203124     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.03.030     Document Type: Article

References (68)

1. Prat A., Adamo B., Cheang M.C.U., Anders C.K., Carey L.A., Perou C.M. Molecular characterization of basal-like and non-basal-like triple-negative breast cancer. Oncologist 2013, 18:123-133. 10.1634/theoncologist.2012-0397.
2. Calcagno A.M., Salcido C.D., Gillet J.-P., Wu C.-P., Fostel J.M., Mumau M.D., et al. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. J. Natl. Cancer Inst 2010, 102:1637-1652. 10.1093/jnci/djq361.
3. Hankinson S.E., Colditz G.A., Willett W.C. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 2004, 6:213-218. 10.1186/bcr921.
4. Hulka B.S., Moorman P.G. Breast cancer: hormones and other risk factors. Maturitas 2008, 61:203-213. 10.1016/S0378-5122(00)00196-1.
5. John E.M., Phipps A.I., Knight J.A., Milne R.L., Dite G.S., Hopper J.L., et al. Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry. Int. J. Cancer 2007, 121:386-394. 10.1002/ijc.22668.
6. Li X., Lewis M.T., Huang J., Gutierrez C., Osborne C.K., Wu M.-F., et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl. Cancer Inst 2008, 100:672-679. 10.1093/jnci/djn123.
7. Oeffinger K.C., Ford J.S., Moskowitz C.S., Diller L.R., Hudson M.M., Chou J.F., et al. Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA 2009, 301:404-414. 10.1001/jama.2008.1039.
8. Tanei T., Morimoto K., Shimazu K., Kim S.J., Tanji Y., Taguchi T., et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin. Cancer Res 2009, 15:4234-4241. 10.1158/1078-0432.CCR-08-1479.
9. Dressing G.E., Alyea R., Pang Y., Thomas P. Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors. Horm. Cancer 2012, 3:101-112. 10.1007/s12672-012-0106-x.
10. Dressing G.E., Thomas P. Identification of membrane progestin receptors in human breast cancer cell lines and biopsies and their potential involvement in breast cancer. Steroids 2007, 72:111-116. 10.1016/j.steroids.2006.10.006.
11. Karteris E., Zervou S., Pang Y., Dong J., Hillhouse E.W., Randeva H.S., et al. Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term. Mol. Endocrinol 2006, 20:1519-1534. 10.1210/me.2005-0243.
12. Pang Y., Thomas P. Progesterone signals through membrane progesterone receptors (mPRs) in MDA-MB-468 and mPR-transfected MDA-MB-231 breast cancer cells which lack full-length and N-terminally truncated isoforms of the nuclear progesterone receptor. Steroids 2011, 76:921-928. 10.1016/j.steroids.2011.01.008.
13. Pang Y., Dong J., Thomas P. Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors δ and ε (mPRδ and mPRε) and mPRδ involvement in neurosteroid inhibition of apoptosis. Endocrinology 2013, 154:283-295. 10.1210/en.2012-1772.
14. Thomas P., Pang Y., Dong J., Groenen P., Kelder J., de Vlieg J., et al. Steroid and G protein binding characteristics of the seatrout and human progestin membrane receptor alpha subtypes and their evolutionary origins. Endocrinology 2007, 148:705-718. 10.1210/en.2006-0974.
15. Zhu Y., Rice C.D., Pang Y., Pace M., Thomas P. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:2231-2236. 10.1073/pnas.0336132100.
16. Tan W., Thomas P. Activation of the Pi3k/Akt pathway and modulation of phosphodiesterase activity via membrane progestin receptor-alpha (mPRalpha) regulate progestin-initiated sperm hypermotility in Atlantic croaker. Biol. Reprod 2014, 10.1095/biolreprod.113.112896.
17. Zuo L., Li W., You S. Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway. Breast Cancer Res 2010, 12. R34. 10.1186/bcr2588.
18. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3983-3988. 10.1073/pnas.0530291100.
19. Sheridan C., Kishimoto H., Fuchs R.K., Mehrotra S., Bhat-Nakshatri P., Turner C.H., et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 2006, 8. R59. 10.1186/bcr1610.
20. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567. 10.1016/j.stem.2007.08.014.
21. Ablett M.P., Singh J.K., Clarke R.B. Stem cells in breast tumours: are they ready for the clinic?. Eur. J. Cancer 2012, 48:2104-2116. 10.1016/j.ejca.2012.03.019.
22. Molyneux G., Geyer F.C., Magnay F.-A., McCarthy A., Kendrick H., Natrajan R., et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 2010, 7:403-417. 10.1016/j.stem.2010.07.010.
23. Blanpain C. Tracing the cellular origin of cancer. Nat. Cell Biol 2013, 15:126-134. 10.1038/ncb2657.
24. DiRenzo J., Signoretti S., Nakamura N., Rivera-Gonzalez R., Sellers W., Loda M., et al. Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line. Cancer Res 2002, 62:89-98.
25. Debnath J., Muthuswamy S.K., Brugge J.S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003, 30:256-268.
26. Charafe-Jauffret E., Ginestier C., Iovino F., Wicinski J., Cervera N., Finetti P., et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 2009, 69:1302-1313. 10.1158/0008-5472.CAN-08-2741.
27. Asiedu M.K., Ingle J.N., Behrens M.D., Radisky D.C., Knutson K.L. TGFβ/TNFα-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res 2011, 71:4707-4719. 10.1158/0008-5472.CAN-10-4554.
28. Morel A.-P., Lièvre M., Thomas C., Hinkal G., Ansieau S., Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008, 3. e2888. 10.1371/journal.pone.0002888.
29. Hirsch H.A., Iliopoulos D., Tsichlis P.N., Struhl K. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 2009, 69:7507-7511. 10.1158/0008-5472.CAN-09-2994.
30. Iliopoulos D., Hirsch H.A., Wang G., Struhl K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. PNAS 2011, 108:1397-1402. 10.1073/pnas.1018898108.
31. Vares G., Cui X., Wang B., Nakajima T., Nenoi M. Generation of breast cancer stem cells by steroid hormones in irradiated human mammary cell lines. PLoS ONE 2013, 8. e77124. 10.1371/journal.pone.0077124.
32. Takahashi R.-U., Miyazaki H., Ochiya T. The role of microRNAs in the regulation of cancer stem cells. Front. Genet 2014, 4. 10.3389/fgene.2013.00295.
33. Iliopoulos D., Lindahl-Allen M., Polytarchou C., Hirsch H.A., Tsichlis P.N., Struhl K. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol. Cell 2010, 39:761-772. 10.1016/j.molcel.2010.08.013.
34. Ibarra I., Erlich Y., Muthuswamy S.K., Sachidanandam R., Hannon G.J. A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev 2007, 21:3238-3243. 10.1101/gad.1616307.
35. Cittelly D.M., Finlay-Schultz J., Howe E.N., Spoelstra N.S., Axlund S.D., Hendricks P., et al. Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. Oncogene 2012, 32:2555-2564. 10.1038/onc.2012.275.
36. Mott J.L., Kurita S., Cazanave S.C., Bronk S.F., Werneburg N.W., Fernandez-Zapico M.E. Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J. Cell. Biochem 2010, 110:1155-1164. 10.1002/jcb.22630.
37. Wang H., Garzon R., Sun H., Ladner K.J., Singh R., Dahlman J., et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008, 14:369-381. 10.1016/j.ccr.2008.10.006.
38. Liu S., Wu L.-C., Pang J., Santhanam R., Schwind S., Wu Y.-Z., et al. Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell 2010, 17:333-347. 10.1016/j.ccr.2010.03.008.
39. Akaogi K., Nakajima Y., Ito I., Kawasaki S., Oie S.-H., Murayama A., et al. KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERα. Oncogene 2009, 28:2894-2902. 10.1038/onc.2009.151.
40. Fernandes M.S., Pierron V., Michalovich D., Astle S., Thornton S., Peltoketo H., et al. Regulated expression of putative membrane progestin receptor homologues in human endometrium and gestational tissues. J. Endocrinol 2005, 187:89-101. 10.1677/joe.1.06242.
41. Herfs M., Hubert P., Kholod N., Caberg J.H., Gilles C., Berx G., et al. Transforming growth factor-β1-mediated slug and snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression. Am. J. Pathol 2008, 172:1391-1402. 10.2353/ajpath.2008.071004.
42. Li H., Sun L., Xu Y., Li Z., Luo W., Tang Z., et al. Overexpression of MTA3 correlates with tumor progression in non-small cell lung cancer. PLoS ONE 2013, 8. e66679. 10.1371/journal.pone.0066679.
43. Kelder J., Azevedo R., Pang Y., de Vlieg J., Dong J., Thomas P. Comparison between steroid binding to membrane progesterone receptor alpha (mPRalpha) and to nuclear progesterone receptor: correlation with physicochemical properties assessed by comparative molecular field analysis and identification of mPRalpha-specific agonists. Steroids 2010, 75:314-322. 10.1016/j.steroids.2010.01.010.
44. Keymeulen A.V., Rocha A.S., Ousset M., Beck B., Bouvencourt G., Rock J., et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011, 479:189. 10.1038/nature10573.
45. Charafe-Jauffret E., Ginestier C., Monville F., Finetti P., Adélaïde J., Cervera N., et al. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 2006, 25:2273-2284. 10.1038/sj.onc.1209254.
46. Pires M.M., Hopkins B.D., Saal L.H., Parsons R.E. Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells. Cancer Biol. Ther 2013, 14:246-253. 10.4161/cbt.23297.
47. Croucher D.R., Hochgräfe F., Zhang L., Liu L., Lyons R.J., Rickwood D., et al. Involvement of lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathway. Cancer Res 2013, 73:1969-1980. 10.1158/0008-5472.CAN-12-1472.
48. Clarke R.B., Howell A., Potten C.S., Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 1997, 57:4987-4991.
49. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H.M., Jones D.L., et al. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006, 66:9339-9344. 10.1158/0008-5472.CAN-06-3126.
50. Behera M.A., Dai Q., Garde R., Saner C., Jungheim E., Price T.M. Progesterone stimulates mitochondrial activity with subsequent inhibition of apoptosis in MCF-10A benign breast epithelial cells. Am. J. Physiol. Endocrinol. Metab 2009, 297:E1089-E1096. 10.1152/ajpendo.00209.2009.
51. Krämer E.A., Seeger H., Krämer B., Wallwiener D., Mueck A.O. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells. Eur. J. Obstet. Gynecol. Reprod. Biol 2006, 129:77-83. 10.1016/j.ejogrb.2005.12.004.
52. Krämer E.A., Seeger H., Krämer B., Wallwiener D., Mueck A.O. Characterization of the stimulatory effect of medroxyprogesterone acetate and chlormadinone acetate on growth factor treated normal human breast epithelial cells. J. Steroid Biochem. Mol. Biol 2006, 98:174-178. 10.1016/j.jsbmb.2005.11.002.
53. Vares G., Ory K., Lectard B., Levalois C., Altmeyer-Morel S., Chevillard S., et al. Progesterone prevents radiation-induced apoptosis in breast cancer cells. Oncogene 2004, 23:4603-4613. 10.1038/sj.onc.1207601.
54. Dubrovska A., Kim S., Salamone R.J., Walker J.R., Maira S.-M., García-Echeverría C., et al. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. PNAS 2009, 106:268-273. 10.1073/pnas.0810956106.
55. Fang D.D., Zhang C.C., Gu Y., Jani J.P., Cao J., Tsaparikos K., et al. Antitumor efficacy of the dual PI3K/mTOR inhibitor PF-04691502 in a human xenograft tumor model derived from colorectal cancer stem cells harboring a PIK3CA mutation. PLoS ONE 2013, 8. e67258. 10.1371/journal.pone.0067258.
56. Mueller M.-T., Hermann P.C., Witthauer J., Rubio-Viqueira B., Leicht S.F., Huber S., et al. Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. Gastroenterology 2009, 137:1102-1113. 10.1053/j.gastro.2009.05.053.
57. Hardt O., Wild S., Oerlecke I., Hofmann K., Luo S., Wiencek Y., et al. Highly sensitive profiling of CD44+/CD24- breast cancer stem cells by combining global mRNA amplification and next generation sequencing: evidence for a hyperactive PI3K pathway. Cancer Lett 2012, 325:165-174. 10.1016/j.canlet.2012.06.010.
58. Pandolfi P.P. Breast cancer - loss of pten predicts resistance to treatment. N. Engl. J. Med 2004, 351:2337-2338. 10.1056/NEJMcibr043143.
59. Joshi B., Strugnell S.S., Goetz J.G., Kojic L.D., Cox M.E., Griffith O.L., et al. Phosphorylated caveolin-1 regulates rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion. Cancer Res 2008, 68:8210-8220. 10.1158/0008-5472.CAN-08-0343.
60. Obr A.E., Edwards D.P. The biology of progesterone receptor in the normal mammary gland and in breast cancer. Mol. Cell. Endocrinol 2012, 357:4-17. 10.1016/j.mce.2011.10.030.
61. Wu Y., Deng J., Rychahou P.G., Qiu S., Evers B.M., Zhou B.P. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 2009, 15:416-428. 10.1016/j.ccr.2009.03.016.
62. Heiden K.B., Williamson A.J., Doscas M.E., Ye J., Wang Y., Liu D., et al. The sonic hedgehog signaling pathway maintains the cancer stem cell self-renewal of anaplastic thyroid cancer by inducing snail expression. J. Clin. Endocrinol. Metab 2014, 99:E2178-E2187. 10.1210/jc.2014-1844.
63. Mani S.A., Guo W., Liao M.-J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715. 10.1016/j.cell.2008.03.027.
64. Kriegel A.J., Liu Y., Fang Y., Ding X., Liang M. The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol. Genomics 2012, 44:237-244. 10.1152/physiolgenomics.00141.2011.
65. Wang Y., Zhou B.P. Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin. J. Cancer 2011, 30:603-611. 10.5732/cjc.011.10226.
66. Scheel C., Weinberg R.A. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin. Cancer Biol 2012, 22:396-403. 10.1016/j.semcancer.2012.04.001.
67. Li H.-F., Kim J.-S., Waldman T. Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells. Radiat. Oncol 2009, 4:43. 10.1186/1748-717X-4-43.
68. Valerie K., Yacoub A., Hagan M.P., Curiel D.T., Fisher P.B., Grant S., et al. Radiation-induced cell signaling: inside-out and outside-in. Mol. Cancer Ther 2007, 6:789-801. 10.1158/1535-7163.MCT-06-0596.